Metabolix, an innovation driven bioscience company focused on providing sustainable solutions for the world’s needs for plastics, chemicals and energy, announced yesterday (June 22) that Telles, the joint venture between Metabolix and Archer Daniels Midland Company that produces Mirel bioplastics, has developed its next generation of injection molding bioplastic, Mirel P1003, in a collaborative effort with Nypro, a leading global precision plastics molder.
Mirel P1003 is the second generation of Mirel for injection molding, replacing both P1001 and P1002 with a single grade suitable for a wider range of applications. This high performance biobased semi-crystalline polyester is tough, durable, and has excellent resistance to heat, making it a suitable replacement for high performance materials including ABS and polycarbonate. Advanced attributes of Mirel P1003 are overall improved processability, improved flow, faster overall cycle times compared to other biopolymers, and an overall cycle time similar to traditional thermoplastics.
Source: plastics.2456.com
